TGTX - TG Therapeutics, Inc.

NasdaqCM - NasdaqCM Real Time Price. Currency in USD
Currency in USD
Earnings EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts6676
Avg. Estimate-0.43-0.42-1.59-1.35
Low Estimate-0.49-0.49-1.91-1.71
High Estimate-0.32-0.29-1.15-0.84
Year Ago EPS-0.59-0.59-2.3-1.59
Revenue EstimateCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
No. of Analysts5566
Avg. Estimate20k20k130k19.12M
Low EstimateN/AN/AN/A150k
High Estimate40k40k200k53M
Year Ago Sales38k38k152k130k
Sales Growth (year/est)-47.40%-47.40%-14.50%14,607.70%
Earnings History3/30/20186/29/20189/29/201812/30/2018
EPS Est.-0.44-0.53-0.54-0.44
EPS Actual-0.59-0.59-0.43-0.69
Difference-0.15-0.060.11-0.25
Surprise %-34.10%-11.30%20.40%-56.80%
EPS TrendCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Current Estimate-0.43-0.42-1.59-1.35
7 Days Ago-0.43-0.42-1.59-1.35
30 Days Ago-0.42-0.38-1.55-1.49
60 Days Ago-0.37-0.31-1.53-1.73
90 Days Ago-0.37-0.31-1.56-1.82
EPS RevisionsCurrent Qtr. (Mar 2019)Next Qtr. (Jun 2019)Current Year (2019)Next Year (2020)
Up Last 7 DaysN/AN/AN/AN/A
Up Last 30 DaysN/AN/AN/AN/A
Down Last 7 DaysN/AN/AN/AN/A
Down Last 30 Days1112
Growth EstimatesTGTXIndustrySectorS&P 500
Current Qtr.27.10%N/AN/A-0.02
Next Qtr.28.80%N/AN/A0.04
Current Year30.90%N/AN/A0.05
Next Year15.10%N/AN/A0.11
Next 5 Years (per annum)N/AN/AN/A0.10
Past 5 Years (per annum)N/AN/AN/AN/A